Director TitleAgeSince
Chairman - -
Chairman - 27/06/2012
Director/Board Member - 23/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
+0.21%-7.67%+61.07%+71.32% 68.92B
+1.66%+7.51%+8.12%+61.40% 51.9B
+3.14%+7.17%+12.48%+41.70% 48.73B
+3.40%+4.61%+33.33%+36.10% 43.13B
-1.18%+1.29%+284.48%+458.47% 41.48B
+6.46%+6.66%+18.12%+114.69% 39.96B
+1.28%-0.76%+12.67%+45.10% 30.6B
-2.21%-14.22%+40.33%-0.94% 26.01B
+1.91%-1.99%-13.53%-6.96% 22.27B
Average +1.58%-3.90%+50.79%+91.21% 41.44B
Weighted average by Cap. +1.68%-3.49%+54.52%+97.84%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock